News tagged with clinical response
Germ-line <i>BRCA1/2</i> testing recommended in ovarian cancer
(HealthDay) -- Due to the potential survival and treatment response implications of BRCA mutation status, it is recommended that germ-line BRCA1/2 testing be offered to all women diagnosed with nonmucinous o ...
Cancer
Jun 19, 2012 |
not rated yet |
0
Drug combination highly effective for newly diagnosed myeloma patients
A three-drug treatment for the blood cancer multiple myeloma provided rapid, deep and potentially durable responses, researchers report today online in Blood, the Journal of the American Society of Hematology, and yester ...
Cancer
Jun 04, 2012 |
not rated yet |
0
|
Study IDs immune system glitch tied to fourfold higher likelihood of death
Mayo Clinic researchers have identified an immune system deficiency whose presence shows someone is up to four times likelier to die than a person without it. The glitch involves an antibody molecule called a free light chain; ...
Immunology
Jun 04, 2012 |
5 / 5 (1) |
0
|
A boost in microRNA may protect against sepsis and other inflammatory diseases
Acute inflammatory diseases, such as sepsis, as well as chronic inflammatory diseases like diabetes and arthritis, develop as a result of sustained inflammation of the blood vessel wall. Researchers at Brigham and Women's ...
Inflammatory disorders
May 24, 2012 |
5 / 5 (1) |
0
|
Breast MRI helps predict chemotherapy's effectiveness
Magnetic resonance imaging (MRI) provides an indication of a breast tumor's response to pre-surgical chemotherapy significantly earlier than possible through clinical examination, according to a new study published online ...
Cancer
May 23, 2012 |
not rated yet |
0
Hybrid vaccine demonstrates potential to prevent breast cancer recurrence
A breast cancer vaccine already shown to elicit a powerful immune response in women with varying levels of HER2 expression has the ability to improve recurrence rates and is well tolerated in an adjuvant setting, according ...
Cancer
May 17, 2012 |
5 / 5 (4) |
0
|
Cancer vaccine combination therapy shows survival benefit in breast cancer
A vaccine that targets cancer cells in combination with the drug letrozole, a standard hormonal therapy against breast cancer, significantly increased survival when tested in mice, a team of UC Davis investigators has found.
Cancer
May 15, 2012 |
not rated yet |
0
Early response is an indicator for rectal cancer survival
(HealthDay) -- In patients with locally advanced rectal cancer undergoing radical resection, response to neoadjuvant chemoradiotherapy is an early marker that correlates with rates of recurrence-free survival, ...
Cancer
Apr 10, 2012 |
5 / 5 (1) |
0
Scientists uncover liver's role in preventing dissemination of lung infection
Researchers at Boston University School of Medicine (BUSM) have discovered the regulation and functional significance of the acute phase response during a lung infection. The findings, which will be published in the May edition ...
Medical research
Apr 02, 2012 |
5 / 5 (1) |
0
First volume of the Cancer Cell Line Encyclopedia made public
The goal of cancer treatment is to match the right drug to the right target in the right patient. But before such "personalized" drugs can be developed, more knowledge is needed about specific genomic alterations in cancers ...
Cancer
Mar 28, 2012 |
5 / 5 (1) |
0
|
Cuba to test new AIDS vaccine on humans
Cuba's top biotech teams have successfully tested a new AIDS vaccine on mice, and are ready to soon begin human testing, a leading researcher told a biotechnology conference in Havana on Monday.
HIV & AIDS
Mar 06, 2012 |
5 / 5 (1) |
0
Researchers find potential solution to melanoma's resistance to vemurafenib
Researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues in California have found that the XL888 inhibitor can prevent resistance to the chemotherapy drug vemurafenib, commonly used for treating patients with melanoma.
Cancer
Feb 28, 2012 |
not rated yet |
0
|
New method to manage stress responses for more successful tumor removal
The week before and two weeks after surgery are a critical period for the long-term survival rate of cancer patients. Physiological and psychological stresses caused by the surgery itself can inhibit the body's immune responses, ...
Cancer
Jan 30, 2012 |
not rated yet |
0
First trial of a new hepatitis C vaccine shows promise
(Medical Xpress) -- A new vaccine against the chronic liver disease hepatitis C has shown promising results in a first clinical trial in humans, Oxford University researchers report.
Diseases, Conditions, Syndromes
Jan 05, 2012 |
5 / 5 (4) |
0
|
Another potential obstacle to developing an HIV vaccine
A clinical trial testing a candidate HIV vaccine known as the STEP study was halted in September 2007 after interim analysis indicated that the vaccine did not work.
HIV & AIDS
Dec 27, 2011 |
2 / 5 (2) |
0
